93 related articles for article (PubMed ID: 2331574)
1. Prevention of myocardial enzyme release by ranolazine in a primate model of ischaemia with reperfusion.
Allely MC; Alps BJ
Br J Pharmacol; 1990 Jan; 99(1):5-6. PubMed ID: 2331574
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of ranolazine in guinea-pig hearts during low-flow ischaemia and their association with increases in active pyruvate dehydrogenase.
Clarke B; Spedding M; Patmore L; McCormack JG
Br J Pharmacol; 1993 Jul; 109(3):748-50. PubMed ID: 8358570
[TBL] [Abstract][Full Text] [Related]
3. Ranolazine, a partial fatty acid oxidation inhibitor, reduces myocardial infarct size and cardiac troponin T release in the rat.
Zacharowski K; Blackburn B; Thiemermann C
Eur J Pharmacol; 2001 Apr; 418(1-2):105-10. PubMed ID: 11334871
[TBL] [Abstract][Full Text] [Related]
4. Cardioprotective effects of ranolazine (RS-43285) in the isolated perfused rabbit heart.
Gralinski MR; Black SC; Kilgore KS; Chou AY; McCormack JG; Lucchesi BR
Cardiovasc Res; 1994 Aug; 28(8):1231-7. PubMed ID: 7954626
[TBL] [Abstract][Full Text] [Related]
5. Effect of ranolazine on infarct size in a canine model of regional myocardial ischemia/reperfusion.
Black SC; Gralinski MR; McCormack JG; Driscoll EM; Lucchesi BR
J Cardiovasc Pharmacol; 1994 Dec; 24(6):921-8. PubMed ID: 7898075
[TBL] [Abstract][Full Text] [Related]
6. Brief femoral artery ischaemia provides protection against myocardial ischaemia-reperfusion injury in rats: the possible mechanisms.
Shahid M; Tauseef M; Sharma KK; Fahim M
Exp Physiol; 2008 Aug; 93(8):954-68. PubMed ID: 18356557
[TBL] [Abstract][Full Text] [Related]
7. Emulsified isoflurane produces cardiac protection after ischemia-reperfusion injury in rabbits.
Rao Y; Wang YL; Zhang WS; Liu J
Anesth Analg; 2008 May; 106(5):1353-9, table of contents. PubMed ID: 18420844
[TBL] [Abstract][Full Text] [Related]
8. Ranolazine, an inhibitor of the late sodium channel current, reduces postischemic myocardial dysfunction in the rabbit.
Hale SL; Kloner RA
J Cardiovasc Pharmacol Ther; 2006 Dec; 11(4):249-55. PubMed ID: 17220471
[TBL] [Abstract][Full Text] [Related]
9. The antianginal agent, ranolazine, reduces myocardial infarct size but does not alter anatomic no-reflow or regional myocardial blood flow in ischemia/reperfusion in the rabbit.
Hale SL; Kloner RA
J Cardiovasc Pharmacol Ther; 2008 Sep; 13(3):226-32. PubMed ID: 18625805
[TBL] [Abstract][Full Text] [Related]
10. A comparison between ranolazine and CVT-4325, a novel inhibitor of fatty acid oxidation, on cardiac metabolism and left ventricular function in rat isolated perfused heart during ischemia and reperfusion.
Wang P; Fraser H; Lloyd SG; McVeigh JJ; Belardinelli L; Chatham JC
J Pharmacol Exp Ther; 2007 Apr; 321(1):213-20. PubMed ID: 17202401
[TBL] [Abstract][Full Text] [Related]
11. Modulation of alpha 1-adrenoceptors in rat left ventricle by ischaemia and acyl carnitines: protection by ranolazine.
Allely MC; Brown CM; Kenny BA; Kilpatrick AT; Martin A; Spedding M
J Cardiovasc Pharmacol; 1993 Jun; 21(6):869-73. PubMed ID: 7687710
[TBL] [Abstract][Full Text] [Related]
12. Effects of reperfusion and superoxide dismutase on myocardial infarct size in a closed chest pig model.
Näslund U; Häggmark S; Johansson G; Pennert K; Reiz S; Marklund SL
Cardiovasc Res; 1992 Feb; 26(2):170-8. PubMed ID: 1571937
[TBL] [Abstract][Full Text] [Related]
13. Regional myocardial ajmaline concentration and antiarrhythmic activity for ischaemia- and reperfusion-induced arrhythmias in rats.
Okumura K; Hashimoto Y; Yasuhara M; Hori R
Br J Pharmacol; 1988 Apr; 93(4):827-32. PubMed ID: 3390652
[TBL] [Abstract][Full Text] [Related]
14. Improved left ventricular function and reduced necrosis after myocardial ischemia/reperfusion in rabbits treated with ranolazine, an inhibitor of the late sodium channel.
Hale SL; Leeka JA; Kloner RA
J Pharmacol Exp Ther; 2006 Jul; 318(1):418-23. PubMed ID: 16617168
[TBL] [Abstract][Full Text] [Related]
15. Reperfusion induced enzyme release: washout effect or manifestation of reperfusion damage?
Mohanlal RW; Mauve I; Zoet AC; van der Laarse A
Cardiovasc Res; 1988 Sep; 22(9):603-10. PubMed ID: 3242831
[TBL] [Abstract][Full Text] [Related]
16. Effects of brief periods of myocardial ischemia on regional myocardial function and creatine kinase release in conscious dogs and baboons.
Vatner SF; Heyndrickx GR; Fallon JT
Can J Cardiol; 1986 Jul; Suppl A():19A-24A. PubMed ID: 3756586
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of 1-(2,6-dimethylphenoxy)-2-(3,4-dimethoxyphenylethylamino) propane hydrochloride on myocardial ischemia-reperfusion injury in rats.
Wang CJ; Gao MT; Wu YJ; Liu JT
Pharmazie; 2005 Dec; 60(12):934-8. PubMed ID: 16398271
[TBL] [Abstract][Full Text] [Related]
18. The effects of the novel anti-anginal compound RS 43285 on myocardial conduction in the anaesthetized dog.
Allely MC; Alps BJ
Br J Pharmacol; 1988 Feb; 93(2):375-82. PubMed ID: 3359110
[TBL] [Abstract][Full Text] [Related]
19. Effect of desflurane-induced preconditioning following ischemia-reperfusion on nitric oxide release in rabbits.
Tsai SK; Lin SM; Huang CH; Hung WC; Chih CL; Huang SS
Life Sci; 2004 Dec; 76(6):651-60. PubMed ID: 15567190
[TBL] [Abstract][Full Text] [Related]
20. Antitorsadogenic effects of ({+/-})-N-(2,6-dimethyl-phenyl)-(4[2-hydroxy-3-(2-methoxyphenoxy)propyl]-1-piperazine (ranolazine) in anesthetized rabbits.
Wang WQ; Robertson C; Dhalla AK; Belardinelli L
J Pharmacol Exp Ther; 2008 Jun; 325(3):875-81. PubMed ID: 18322148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
